Skip to main content
. 2010 Aug 4;35(12):2367–2377. doi: 10.1038/npp.2010.111

Figure 2.

Figure 2

Kaplan–Meier estimate of relapse-free time. Among 327 subjects treated with risperidone long-acting injectable (RLAI), relapse occurred in 54; among the 326 subjects treated with quetiapine, relapse occurred in 102. Censored subjects are those not relapsing by the time of assessment.